Desk›Healthcare› Vivimed Labs Ltd
Vivimed Labs Ltd
BSE 532660 · NSE VIVIMEDLAB · ISIN INE526G01021 · Group T · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹6.94
+1.91%
BSE close, 28 August 2026
₹57.54 cr
8.3 cr shares · Micro cap
₹44.99 cr
as published
-0.3× · 0.83×
EPS ₹-20.59 · BV ₹8.36
55.78 / -170.68
₹ cr, as filed
5
2 selected · 40%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -75.2% |
|---|---|
| Against 52-week low | +45.8% |
| Day change | +1.91% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹-20.59 |
|---|---|
| Price / earnings | -0.34× |
| Price / book | 0.83× |
| Book value — derived, price ÷ P/B | ₹8.36 |
| Return on equity | -246.28% |
| Operating margin | -1,802.64% |
| Net margin | -1,870.14% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- -244.12%
- ROE as published
- -246.28%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Mar-26 · Q | 7.55 | -141.18 | -17.14 | -1,802.64% | -1,870.14% |
| Dec-25 · Q | 11.63 | -16.57 | -2.00 | -96.47% | -142.43% |
| FY25-26 | 55.78 | -170.68 | -20.59 | -266.47% | -305.98% |
Quarter on quarter
- Revenue, quarter on quarter
- -35.1%
- Net profit, quarter on quarter
- -752.0%
- Operating margin, quarter on quarter
- -170,617 bps
Disclosure profile 5 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| CIRP | 2 |
| Selected sub-total | 2 |
| Procedural | |
| General | 1 |
| Newspaper Publication | 1 |
| Trading Window | 1 |
| Procedural sub-total | 3 |
| Total | 5 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group T, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
5 filings · 2 selected · busiest 2026-07-22
Filing rhythm · the twelve most recent
2026-07-222026-09-23
SelectedProcedural
Filings
5 in the window · 5 earlier on record
-
23 September 2026 ·
Closure of Trading Window
closure of trading window
Insider Trading / SAST / Closure of Trading Window View filing →
-
8 September 2026 ·
Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
Committee of Creditors meeting on 10th September 2026
Company Update / Intimation of meeting of Committee of Creditors View filing →
-
17 August 2026 ·
Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
6th COC meeting on 18th August 2026
Company Update / Intimation of meeting of Committee of Creditors View filing →
-
22 July 2026 ·
Re- Lodgement Of Transfer Requests
re-lodgement of transfer requests
Company Update / General View filing →
-
22 July 2026 ·
Newspaper Publication
news paper publication for march 2026 results
Company Update / Newspaper Publication View filing →
RSS feed for Vivimed Labs Ltd · the 50 most recent filings